Estrella Immunopharma Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Estrella Immunopharma Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ESLA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001844417
Board of directors
-
Cheng Liu · Director · Chief Executive OfficerSince 2023
-
Fan Wu · DirectorSince 2023
-
Hong Zhang · DirectorSince 2024
-
Marsha Roberts · DirectorSince 2023
-
Pei Xu · DirectorSince 2023
-
Xuejun Janelle Wu · DirectorSince 2023
Chief executives
Cheng Liu
· Chief Executive Officer
Since September 2023
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 29, 2023 | Jeffrey A. Altman 10% owner | Other | −255,000 | $10.86 | $2,769,300 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.